跳至主要内容
附件 II 条目 1697 已修订 24 八月 2023

Dibutyltin di(acetate)

Dibutyltin di(acetate) 在附件 II 中被列为在欧盟市场上市的化妆品的禁用物质。

禁用物质— 附件 II, 欧盟法规 1223/2009
条目: 1697

记录详情

化学名称

Dibutyltin di(acetate)

监管信息

法规

(EU) 2023/1490

查看该法案设定的所有条目

关键数据

附件
条目编号
1697

化学身份与性质

CAS 1067-33-0 的 PubChem 二维化学结构
CAS 1067-33-0PubChem CID 16682740

Dibutyltin diacetate

Dibutyltin diacetate is a clear yellow liquid. (NTP, 1992) — CAMEO Chemicals

IUPAC 名称
[acetyloxy(dibutyl)stannyl] acetate
分子式
C12H24O4Sn
分子量
351.03 g/mol
精确质量
352.069662 Da
拓扑极性表面积
52.6 Ų
氢键供体
0
氢键受体
4
共价单元
1
已定义的立体中心
0

又称

DiacetoxybutyltinDiacetoxydibutyltinDiacetoxydibutylstannaneStannane, bis(acetyloxy)dibutyl-Di-n-butyltin diacetateBis(acetyloxy)dibutylstannaneT 1 (Catalyst)Stannane, diacetoxydibutyl-
另有 16 个已报告名称
Dibutylstannium diacetateFomrez sul-3DiacetoxydibutlyltinDibutyl tin diacetateDibutyltin di(acetate)Dibutyltin acetateTin, dibutyl-, diacetateBA 2726NCI-C02028DibutyldiacetoxystannaneBC9AZH1UZGNSC 8786Acetic acid, 1,1'-(dibutylstannylene) esterNSC-8786Dibutly Tin DiacetateRefChem:586576
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配16682740

Attributed physical-property, hazard, environmental and use annotations.

  • Substance: Dibutyltin diacetate 来源: NTP Technical Reports
  • NTP Technical Report: TR-183: Bioassay of Dibutyltin Diacetate for Possible Carcinogenicity (CASRN 1067-33-0) (1979 ) 来源: NTP Technical Reports
  • Peer Review Date: 10/25/78 来源: NTP Technical Reports
  • Conclusion for Male Rat: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Rat: Inadequate Experiment 来源: NTP Technical Reports
  • Conclusion for Male Mice: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Mice: No Evidence 来源: NTP Technical Reports
  • Summary: Under the conditions of this bioassay, there was no conclusive evidence for the carcinogenicity of dibutyltin diacetate in male Fischer 344 rats or B6C3F1 mice of either sex. The loss of tissues taken from high dose female rats in this bioassay precluded an evaluation of the carcinogenicity of dibutyltin diacetate to female Fischer 344 rats. 来源: NTP Technical Reports
  • Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 来源: Toxin and Toxin Target Database (T3DB)
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. IMMEDIATELY call a hospital or poison control center even if no symptoms (such as redness or irritation) develop. IMMEDIATELY transport the victim to a hospital for treatment after washing the affected areas.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknow 来源: CAMEO Chemicals
  • Signal: Danger 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H360FD: May damage fertility; May damage the unborn child [Danger Reproductive toxicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement) 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Note: This chemical does not meet GHS hazard criteria for 1.5% (10 of 665) of reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Danger 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H314 (94.7%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H317 (82%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H318 (76.5%): Causes serious eye damage [Danger Serious eye damage/eye irritation]; H341 (82.4%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H360 (64.4%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H360FD (18.2%): May damage fertility; May damage the unborn child [Danger Reproductive toxicity]; H370 (82%): Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H372 (92.3%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H400 (58.6%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]; H410 (89%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P260, P261, P264, P264+P265, P270, P272, P273, P280, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P308+P316, P316, P317, P318, P319, P321, P333+P317, P362+P364, P363, P391, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 665 reports by companies from 44 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 10 of 665 reports by companies.; There are 43 notifications provided by 655 of 665 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Signal: Danger 来源: NITE-CMC
  • GHS Hazard Statements: H300: Fatal if swallowed [Danger Acute toxicity, oral]; H360: May damage fertility or the unborn child [Danger Reproductive toxicity]; H373: May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]; H400: Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]; H410: Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard] 来源: NITE-CMC
  • Precautionary Statement Codes: P203, P260, P264, P270, P273, P280, P301+P316, P318, P319, P321, P330, P391, P405, and P501 (click each P-code to see the statement) 来源: NITE-CMC
  • Signal: Danger 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • Health Effects: Breathing or swallowing, or skin contact with organotins, can interfere with the way the brain and nervous system work, causing death in severe cases. Organic tin compounds may also damage the immune and reproductive system. (L307, L308) 来源: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: Organotin compounds produce neurotoxic and immunotoxic effects. Organotins may directly activate glial cells contributing to neuronal cell degeneration by local release of pro-inflammatory cytokines, tumor necrosis factor-_, and/or interleukins. They may also induce apoptosis by direct action on neuronal cells. Organotin compounds stimulate the neuronal release of and/or decrease of neuronal cell uptake of neurotransmitters in brain tissue, including aspartate, GABA, glutamate, norepinephrine, and serotonin. This may be either a contributing factor to or result of the neuronal cell loss. The immunotoxic effects of organotins are characterized by thymic atrophy caused by the suppression of proliferation of immature thymocytes and apoptosis of mature thymocytes. Organotin compounds are believed to exert these effects by suppressing DNA and protein synthesis, inducing the expression of genes involved in apoptosis (such as nur77), and disrupting the regulation of intracellular calcium levels, giving rise to the uncontrolled production of reactive oxygen species, release of cytochrome c to the cytosol, and the proteolytic and nucleolytic cascade of apoptosis. The suppression of prolifer 来源: Toxin and Toxin Target Database (T3DB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
EMBL-EBI ChEBI无精确记录2026-08-31
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

该记录的直接匹配结果有限,因此同时显示附件 II 中的相邻条目。

附件 II 1695
同一附件中的相邻记录

Ammonium bromide

CAS: 12124-97-9
EC: 235-183-8
附件 II 1703
同一附件中的相邻记录

Benzophenone

CAS: 119-61-9
EC: 204-337-6

附件 II 对 Dibutyltin di(acetate) 意味着什么

Dibutyltin di(acetate) 被列为欧盟化妆品法规 1223/2009 附件 II 中的禁用物质,不得有意添加。第 17 条另行规定了在良好生产规范下技术上不可避免、且符合第 3 条安全要求的非有意微量存在的情形。

配方师必须筛查其成分和原料,确保均不含该物质。供应商应在被要求时提供证明不含该物质的文件。

本页还显示 12 条相关附件记录,其标识符、附件逻辑或命名模式存在重叠。

合规核查清单

  • 核实该物质不存在于所有原料和成品配方中。
  • 向原料供应商索取不含该物质的确认函或 CoA。
  • 将筛查结果记录在产品信息档案 (PIF) 中。

常见问题

是。Dibutyltin di(acetate) 列于欧盟化妆品法规 1223/2009 的附件 II,禁止作为化妆品成分有意添加。第 17 条对在良好生产规范下技术上不可避免的非有意微量存在规定了狭窄的例外,前提是产品仍符合第 3 条的安全要求。

CAS 1067-33-0 是化学文摘社 (Chemical Abstracts Service) 分配给 Dibutyltin di(acetate) 的唯一数字标识符。在化妆品合规工作中,CAS 编号用于在监管数据库、原料规格书和安全评估报告之间交叉引用该物质。如果同一物质在不同条件下或不同附件中出现,多个欧盟附件条目可能共用同一 CAS 编号。

使用本站的 INCI 检查器工具粘贴您的完整成分表 (INCI),并对照所有附件 II–VI 条目进行扫描。该工具会突出显示与限用、禁用或致敏原标记记录相匹配的成分。这有助于对成品配方或原料声明进行快速合规筛查。

附件 II 记录 Dibutyltin di(acetate) 的来源说明

本页概述欧盟委员会公开化妆品资料中 Dibutyltin di(acetate) 的一条附件 II 记录,并在可用时补充关联的清单或标识符匹配。

请使用本记录页面查看 Dibutyltin di(acetate) 的附件 II 条件,但任何最终监管决定都应对照现行官方附件措辞和来源文件确认。

工具与后续步骤

检查您的配方

粘贴完整的 INCI 成分表,一次性检出 Dibutyltin di(acetate) 及其他被标记的欧盟附件记录。

INCI 检查器

条目对比

将 Dibutyltin di(acetate) 与另一条附件记录并排对比,查看限制、浓度和附件归属的差异。

对比

浏览附件

查看附件 II 中的所有记录,并对比该附件中各物质的监管条件。

打开附件 II